Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clinical Trials Breast CancerGeorgia

Breast Cancer Clinical Trials in Georgia

Find 690 clinical trials for breast cancer near Georgia. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Georgia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 481-500 of 690 trials

Active not recruitingAdditional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal TherapyThis phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take…NCT04379570·Birmingham, Alabama and 525 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingSequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBCThe purpose of this research study is to see if the medication sacituzumab govitecan (SG) is effective at the currently approved dose and schedule in people who have previously…NCT06263543·Miami, Florida and 2 others

CompletedA Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast CancerThis is a global Phase III, double-blind, randomized, placebo-controlled study designed to evaluate the efficacy and safety of neoadjuvant treatment with atezolizumab…NCT03197935·Palo Alto, California and 67 others

TerminatedRandomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal TherapyThis is a multicenter, randomized, double-blind study of fulvestrant plus erlotinib versus fulvestrant plus placebo for subjects with metastatic breast cancer whose disease…NCT00570258·Jonesboro, Arkansas and 5 others

CompletedStudy of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.The main aim of this study was to evaluate the efficacy and safety of adding ribociclib to fulvestrant in men and postmenopausal women with hormone receptor positive (HR+)…NCT02422615·Mobile, Alabama and 173 others

CompletedLEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)The purpose of this signal seeking study was to determine whether treatment with LEE011 demonstrates sufficient efficacy in CDK4/6 pathway activated solid tumors and/or…NCT02187783·Birmingham, Alabama and 60 others

RecruitingA Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.The purpose of this study is to learn about the safety and effects of the study medicine PF-07248144 when given along with fulvestrant for the possible treatment of HR-positive…NCT07062965·Anchorage, Alaska and 432 others

RecruitingStudy of XB010 in Subjects With Solid TumorsThis is a FIH study is to evaluate the safety, tolerability, PK, immunogenicity, and preliminary antitumor activity of XB010 as a single agent and in combination with…NCT06545331·Irvine, California and 19 others

CompletedMastectomy Reconstruction Outcomes Consortium (MROC) StudyThe MROC Study seeks to evaluate and compare from the patient's point of view the leading options for breast reconstruction after mastectomy.NCT01723423·Washington D.C., District of Columbia and 10 others

CompletedDevelopment of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic CancerAccrue samples for the further development and clinical validation of a blood-based cell-free DNA (cfDNA) quantitative real-time polymerase chain reaction (qPCR) assay as a…NCT03892096·Little Rock, Arkansas and 11 others

TerminatedPivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast CancerThis is a phase 3, multicenter, open-label, randomized active-controlled, parallel group to investigate the efficacy, safety and tolerability of intravenous balixafortide given…NCT03786094·Fresno, California and 87 others

CompletedNOLAN: Naproxen or Loratadine and NeulastaThe primary objective of the study is to estimate the difference in bone pain between breast cancer patients receiving chemotherapy and pegfilgrastim and either no prophylactic…NCT01712009·Muscle Shoals, Alabama and 82 others

CompletedPhase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase InhibitorThis study was a multi-center, randomized, double-blind, placebo controlled Phase III study to determine the efficacy and safety of treatment with buparlisib plus fulvestrant…NCT01610284·Mobile, Alabama and 267 others

RecruitingA Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib StudyThis is a global extension study to provide continued access to niraparib and further characterize the long-term safety of niraparib treatment in participants who are currently…NCT04641247·Tucson, Arizona and 24 others

CompletedPost Market Study Using the Xoft Axxent SystemThe purpose of this multi-center clinical study is to compile post market performance and safety data on the Axxent System.NCT01017549·San Mateo, California and 9 others

TerminatedClinical Utility of FES F18 PET/CT in Metastatic Breast Cancer PatientsThis is a phase 4, multi-center, open-label, prospective cohort study to evaluate the clinical utility of Fluoroestradiol F18 (Cerianna) PET/CT to guide therapeutic management in…NCT05068726·Flagstaff, Arizona and 23 others

RecruitingEvaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in…NCT05879926·Birmingham, Alabama and 1275 others

TerminatedEfficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast CancerThe purpose of this study is to see if IPI-504 in combination with trastuzamab is an effective treatment in HER2 positive metastatic breast cancerNCT00817362·Palm Springs, California and 10 others

TerminatedPhase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast CancerThis study is a multi-center, randomized, double-blind, placebo-controlled, Phase 2 study in postmenopausal women with heregulin positive, hormone receptor positive, HER2 negative…NCT03241810·Chandler, Arizona and 58 others

CompletedStudy of Ribociclib With Everolimus + Exemestane in HR+ HER2- Locally Advanced/Metastatic Breast Cancer Post Progression on CDK 4/6 Inhibitor.The purpose of this study is determine if the triplet combination of ribociclib, everolimus and exemastane is safe and effective in the treatment of locally advanced/metastatic…NCT02732119·Chandler, Arizona and 24 others

PreviousPage 25 of 35Next

Other Conditions in Georgia

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma